|
Volumn 23, Issue 4, 2003, Pages 1179-1186
|
The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
425(SCFV) ETA';
425(SCFV)-ETA';
EPIDERMAL GROWTH FACTOR;
HYBRID PROTEIN;
IMMUNOTOXIN;
LIGAND;
RECOMBINANT PROTEIN;
SCFV 425;
ARTICLE;
BIOLOGICAL MODEL;
CARCINOMA;
CELL DIVISION;
CHEMISTRY;
DOSE RESPONSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ESCHERICHIA COLI;
FLOW CYTOMETRY;
HUMAN;
IC 50;
IMMUNOGLOBULIN VARIABLE REGION;
IMMUNOTHERAPY;
METABOLISM;
METASTASIS;
MUTATION;
PANCREAS TUMOR;
PLASMID;
PROGNOSIS;
TUMOR CELL LINE;
CARCINOMA;
CELL DIVISION;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EPIDERMAL GROWTH FACTOR;
ESCHERICHIA COLI;
FLOW CYTOMETRY;
HUMANS;
IMMUNOGLOBULIN VARIABLE REGION;
IMMUNOTHERAPY;
IMMUNOTOXINS;
INHIBITORY CONCENTRATION 50;
LIGANDS;
MODELS, GENETIC;
MUTATION;
NEOPLASM METASTASIS;
PANCREATIC NEOPLASMS;
PLASMIDS;
PROGNOSIS;
RECOMBINANT FUSION PROTEINS;
RECOMBINANT PROTEINS;
MLCS;
MLOWN;
|
EID: 3042654883
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.23.4.1179 Document Type: Article |
Times cited : (53)
|
References (0)
|